Peter A Kiener's Net Worth

$2.11 Million

Estimate Recalculated Nov 1, 2024 06:00AM EST

Who is Peter A Kiener?

Peter A Kiener has an estimated net worth of $2.11 Million. This is based on reported shares across multiple companies, which include Sucampo Pharmaceuticals, Inc., PIERIS PHARMACEUTICALS, INC., Cue Biopharma, Inc., and MEDIMMUNE INC /DE.

SEC CIK

Peter A Kiener's CIK is 0001328146

Past Insider Trading and Trends

2017 was Peter A Kiener's most active year for acquiring shares with 7 total transactions. Peter A Kiener's most active month to acquire stocks was the month of December. 2018 was Peter A Kiener's most active year for disposing of shares, totalling 5 transactions. Peter A Kiener's most active month to dispose stocks was the month of January. 2017 saw Peter A Kiener paying a total of $428,498.73 for 254,316 shares, this is the most they've acquired in one year. In 2018 Peter A Kiener cashed out on 553,559 shares for a total of $4,531,540.60, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Sucampo Pharmaceuticals, Inc. No price found

Chief Science Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-44.86K
$18.00
-$807,408.00
0
Feb 13
Form 4
+0.74%
329
$9.10
$2,993.90
44.86K
Dec 31
Form 4
-38.18%
-27.50K
$17.98
-$494,378.08
44.53K
Dec 28
Form 4
—
0
$12.42
-$408,500.00
2.02K
Scheduled
Dec 7
Form 4
+19.49%
330
$9.10
$3,003.00
2.02K
Sep 30
Form 4
+24.76%
336
$8.93
$3,000.48
1.69K
Jun 30
Form 4
+30.98%
321
$9.35
$3,001.35
1.36K
Mar 31
Form 4
∞
70K
—
—
70K
Mar 6
Form 4
+38.32%
287
$10.46
$3,002.02
1.04K
Dec 31
Form 4
+74.59%
320
$9.38
$3,001.60
749
Sep 30
Form 4
+232.56%
300
$9.32
$2,796.00
429
Jun 30
Form 4
∞
129
$9.29
$1,198.41
129
Mar 31
Form 4
—
0
—
—
0
Mar 2
Form 4
—
0
—
—
0
Mar 4
Form 3
—
0
—
—
0
No matching records found

PIERIS PHARMACEUTICALS, INC. (PIRS) Snapshot price: $15

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 25
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jan 25
Form 4
—
0
—
—
0
Jan 25
Form 4
—
0
—
—
0
Oct 24
Form 3
—
0
—
—
0
No matching records found

Cue Biopharma, Inc. (CUE) Snapshot price: $0.7586

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 2
Form 4
∞
357
$3.07
-$2,895.48
357
Mar 23
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
$10.40
-$303,986.66
0
Scheduled
Nov 15 - Nov 16
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jun 12
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

MEDIMMUNE INC /DE No price found

SVP, Research

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 23
Form 4
—
0
$28.43
-$119,554.80
0
Feb 8
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found